Literature DB >> 15136300

Women and heart disease: the role of diabetes and hyperglycemia.

Elizabeth Barrett-Connor1, Elsa-Grace V Giardina, Anselm K Gitt, Uwe Gudat, Helmut O Steinberg, Diethelm Tschoepe.   

Abstract

Cardiovascular disease (CVD) is the primary cause of death in women, and women with type 2 diabetes mellitus are at greater risk of CVD compared with nondiabetic women. The increment in risk attributable to diabetes is greater in women than in men. The extent to which hyperglycemia contributes to heart disease risk has been examined in observational studies and clinical trials, although most included only men or did not analyze sex differences. The probable adverse influence of hyperglycemia is potentially mediated by impaired endothelial function, and/or by other mechanisms. Beyond high blood glucose level, a number of other common risk factors for CVD, including hypertension, dyslipidemia, and cigarette smoking, are seen in women with diabetes and require special attention. Presentation and diagnosis of CVD may differ between women and men, regardless of the presence of diabetes. Recognizing the potential for atypical presentation of CVD in women and the limitations of common diagnostic tools are important in preventing unnecessary delay in initiating proper treatment. Based on what we know today, treatment of CVD should be at least as aggressive in women-and especially in those with diabetes-as it is in men. Future trials should generate specific data on CVD in women, either by design of female-only studies or by subgroup analysis by sex.

Entities:  

Mesh:

Year:  2004        PMID: 15136300     DOI: 10.1001/archinte.164.9.934

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  52 in total

Review 1.  Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2006-03-28

Review 2.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 3.  Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease.

Authors:  Robert H Knopp; Pathmaja Paramsothy; Barbara M Retzlaff; Brian Fish; Carolyn Walden; Alice Dowdy; Christine Tsunehara; Keiko Aikawa; Marian C Cheung
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

4.  Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.

Authors:  Huamei He; Hai Tao; Hui Xiong; Sheng Zhong Duan; Francis X McGowan; Richard M Mortensen; James A Balschi
Journal:  Toxicol Sci       Date:  2014-01-21       Impact factor: 4.849

Review 5.  Effects of dietary fats versus carbohydrates on coronary heart disease: a review of the evidence.

Authors:  Dariush Mozaffarian
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

6.  Shaking and rattling: developing a child obesity prevention program using a faith-based community approach.

Authors:  Elizabeth Reifsnider; Martha Hargraves; Karen Jaynes Williams; John Cooks; Valerie Hall
Journal:  Fam Community Health       Date:  2010 Apr-Jun

7.  Regular Exercise Reduces Endothelial Cortical Stiffness in Western Diet-Fed Female Mice.

Authors:  Jaume Padilla; Francisco I Ramirez-Perez; Javad Habibi; Brian Bostick; Annayya R Aroor; Melvin R Hayden; Guanghong Jia; Mona Garro; Vincent G DeMarco; Camila Manrique; Frank W Booth; Luis A Martinez-Lemus; James R Sowers
Journal:  Hypertension       Date:  2016-08-29       Impact factor: 10.190

8.  Characteristics of men and women with diabetes: observations during patients' initial visit to a diabetes education centre.

Authors:  Enza Gucciardi; Shirley Chi-Tyan Wang; Margaret DeMelo; Lina Amaral; Donna E Stewart
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

9.  Loss of Estrogen Receptor α Signaling Leads to Insulin Resistance and Obesity in Young and Adult Female Mice.

Authors:  Camila Manrique; Guido Lastra; Javad Habibi; Irina Mugerfeld; Mona Garro; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-07-07       Impact factor: 2.041

10.  Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats.

Authors:  Eileen R Blasi; Jonathan Heyen; Michelle Hemkens; Aileen McHarg; Carolyn M Ecelbarger; Swasti Tiwari
Journal:  PPAR Res       Date:  2009-06-11       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.